Common forms of bacterial meningitis Acute bacterial meningitis results from invasion and subsequent inflammation of the meninges by bacteria. Early diagnosis, followed by appropriate antibacterial treatment, should result in cure-while late or inappropriate treatment ends in death or disablement. In spite of the ready availability of effective antibacterial agents the mortality and morbidity from this potentially curable condition remain unacceptably high, especially in neonatal meningitis and pneumococcal meningitis in people over 50. In Britain most cases of bacterial meningitis are caused by the Meningococcus, Pneumococcus, and Haemophilus influenzae, other forms being relatively uncommon.
MENINGOCOCCAL MENINGITIS
Meningococcal meningitis is the commonest form of acute bacterial meningitis in Britain and affects all age groups, with a particularly high mortality at the extremes of life.
The onset of the disease may be remarkably sudden and the patient may die of the sequelae of meningococcaemic consumption coagulopathy before the full-blown meningitic picture arises. More usually the picture is one of acute meningeal irritation in a child or a young adult with fever, variable clouding of consciousness, and an associated petechial or purpuric rash, which is often sparse. Infants may present with grand mal seizures and fever without localising signs.
The clinical diagnosis should be confirmed by examination of the cerebrospinal fluid (CSF) and blood culture. Because of an increasing world-wide incidence of sulphonamide-resistant meningococci, treatment with benzylpenicillin should always be started except in the patient allergic to penicillin, when cephaloridine should be used 1 g six-hourly intravenously in the adult, perhaps with 50 mg intrathecally daily for 3 days. Fourhourly bolus intravenous pulse injections of 2-4 MU in the adult, for five days, should be followed by a further five days of phenoxymethyl penicillin 2 g daily with probenecid. The Those patients who have fulminant meningococcaemia with shock should be given an initial bolus of 200 mg of hydrocortisone, followed by 500 mg-i g hydrocortisone in each bottle of intravenous fluid, each being given over four to six hours. In the early stages of the consumption coagulopathy syndrome bolus injections of heparin 10 000 to 15 000 units four-hourly should be given, as this might prevent the development of the full-blown picture. The prodromal illness may often be less acute than in meningococcal meningitis. A rash is unusual, and deep unconsciousness with fits and cranial nerve palsies are common. Treatment with benzylpenicillin should be started immediately after the CSF has been examined, and blood cultures have been taken. In the adult patient intrathecal injection of 10 000 units of benzylpenicillin should be given at the time of lumbar puncture if pneumococci are seen on the Gram-stained film of the purulent CSF and should be repeated daily for the next three days. Bolus intravenous injections of benzylpenicillin 2-4 MU should be given four-hourly for the first five to seven days, depending on the patient's progress. Thereafter oral phenoxymethyl penicillin therapy 2 g daily with probenecid should be given to a total of 14 days.
If the patient is allergic to penicillin, parenteral cephaloridine 1 g six-hourly and 50 mg daily intrathecally or chloramphenicol 1-2 g six-hourly should be given for not less than five days. In children the dose of chloramphenicol should not exceed 100 mg kg-' day-', and half this dose should be used for neonates. This condition carries an overall mortality of some 1500, while in people over 50 the mortality is more than 50%, The City Hospital, Urquhart Road, Aberdeen AB9 8AU C C SMITH, MB 
Tuberculous meningitis
Tuberculous meningitis is now comparatively uncommon in Britain but should always be remembered in the differential diagnosis of the patient with atypical meningitis. The disease is most common in childhood or early adult life but may occur, and be missed, in the elderly. If diagnosed early and properly treated the condition is curable, but if left untreated is invariably fatal. Inadequate or late treatment results in permanent disablement or death.
Once the diagnosis is established, or even if it seems probable, treatment should be started with intramuscular streptomycin 3 mg kg-' day-' to a maximum of 1 g daily, with oral isoniazid 100 mg eight-hourly and pyridoxine 10 mg daily, with either ethambutol 20 mg kg-' day-' or rifampicin 450-600 mg/day. Daily intrathecal isoniazid 0 5 mg/kg to a maximum of 50 mg daily should be given for a fortnight. The value of corticosteroids is doubtful but many doctors still use daily intrathecal hydrocortisone in a dose of 1 mg/kg with oral prednisolone 40 mg daily. Some experts advocate purified protein derivative in advanced cases in which corticosteroids are of dubious value, except in those patients who develop cerebral oedema, which may be the result of an allergic reaction to tuberculin after treatment starts. Here corticosteroids may be life-saving. I believe that thev should be given in all cases at least for the first week.
Oral chemotherapy should be continued for eighteen months.
Viral meningoencephalitis
Viral meningitis is common and, with the exception of mumps, is due largely to the enteroviruses, particularly the echovirus and Coxsackie viruses. No therapy is available, but antiviral chemotherapy is now available for some forms of meningoencephalitis-notably that due to herpes simplex and varicella herpes zoster. Early treatment should be started with cytarabine 3 mg/kg on the first day, followed by 2 mg/kg daily by bolus intravenous injections for a further three days given with zoster immunoglobulin. This latter treatment is particularly important in immunoincompetent patients where the zoster encephalitis is part of a generalised opportunistic infection.
Q-FEVER
This illness, caused by Coxiella burneti, often presents with headache and neck stiffness, but the CSF in these patients is often normal. Meningoencephalitis is, however, a well-described although rare complication of this febrile systemic illness. Treatment should be given with oxytetracycline 3 mg daily for 10-14 days, except in the seriously ill or semiconscious patient, when intramuscular tetracycline 100 mg four-hourly should be given for 5-7 days depending on the clinical response. Thereafter oral treatment may be introduced.
Toxoplasmosis
Meningoencephalitis with personality or psychotic changes is an uncommon complication of Toxoplasma gondii infection, which is often protracted but seldom fatal. When death does occur, however, it is usually due to meningoencephalitis associated with generalised infection. This is particularly likely to happen in laboratory workers exposed to virulent strains or in the immunoincompetent patient. Treatment should be started with sulphadimidine 3 g daily and pyrimethamine 50-100 mg initially and 25 mg daily, given together for four weeks. Spiramycin is less toxic to the marrow than pyrimethamine but is probably also less effective. If neutropenia or thrombocytopenia arise with the initial combination, then spiramycin 2 g daily should be introduced and continued for ten days with sulphadimidine 3 g daily.
Tetrachel, Tetracyn, Tetrex, Totomycin.
Are any antibiotics secreted in tears and are the concentrations likely to be therapeutic ? Secretion of some antibiotic and chemotherapeutic agents, such as sulphonamides, may be demonstrated in animals. Lacrimal secretion of antibiotics, however, does not result in the appearance of levels of definite therapeutic value in man.
In the past patients with respiratory failure from obstructive airways disease used to become oedematous when they got better. Nowadays diuretics seem to mask this. What is the mechanism of the oedema ?
The cause of oedema in patients with respiratory failure is not clear.' Anoxia may reduce renal blood flow and glomerular filtration rate, leading to retention of sodium, and chronic hypercapnia is accompanied by retention of sodium and bicarbonate ions. Both mechanisms could be responsible for oedema, but the fact that it may persist after recovery, in spite of improvements in renal haemodynamics and arterial blood gas tensions, suggests that other mechanisms are involved.
